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Abstract
Background: There is limited data available on the long-term mental health impact of Ebola virus disease (EVD) on
survivors despite the disease experience of survivors meeting the criteria of a traumatic event as defined in the Diagnostic
and Statistical Manual of Mental Disorders version IV (DSM IV). This study aimed to assess the prevalence and predictive
factors of anxiety, depression and posttraumatic stress disorder among EVD survivors, approximately 2 years after discharge
from the Ebola treatment centre (ETC).
Methods: We conducted a cross-sectional study between May and August 2017 among 197 adults Ebola survivors in
Bombali district, Northern Sierra Leone. We collected information about demographics, mental health status and
possible predictive factors. The HAD scale was used to measure anxiety and depression. PTSD was measured using the
PTSD-checklist (PCL). Chi-square test or Fisher exact two-tailed tests were used to test for associations and the multiple
logistic regressions model to determine factors that were independently associated with the outcome variables.
Results: The mean anxiety, depression and PTSD scores were (5.0 ± 3.9), (7.1 ± 3.8) and (39.5 ± 6.4) respectively. Based on
cut-off scores, the prevalence of anxiety (HADs score≥ 8), depression (HADs score≥ 8) and PTSD (PCL≥ 45) among Ebola
survivors were (n= 49, 24.9%), (n= 93, 47.2%) and (n= 43, 21.8%) respectively. Older Ebola survivors (≥30 years) were more
likely to show symptoms of depression (AOR= 8.5, 95% CI: 2.68–27.01, p= 0.001) and anxiety (AOR = 3.04; 95%CI: 1.2–7.7,
p= 0.019) compared to younger ones (< 30 years). In addition, Ebola survivors who experienced a decreased level of
exercise post-ETC discharge were more likely to show symptoms of depression (AOR= 2.63; 95%CI: 1.25–5.54, p= 0.011) and
anxiety (AOR = 3.60; 95%CI: 1.33–9.72, p= 0.012) compared to those whose exercise remained the same post-ETC discharge.
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Conclusion: Our findings show that anxiety, depression and PTSD are common among the Ebola survivors in Bombali
district, Northern Sierra Leone, and that underscores the need to diagnose and manage mental health morbidities among
Ebola survivors long after their recovery from Ebola virus disease. Cognitive Behaviour Therapy (CBT) and Interpersonal
Therapy (IPT) need to be explored as part of overall mental healthcare package interventions.
Keywords: Anxiety, Depression, Post-traumatic stress disorder, Ebola, Ebola survivor, Sierra Leone
Background
The West African Ebola virus disease (EVD) outbreak was
the largest and worst compared to all previous outbreaks
combined since it was discovered in 1976 [1]. It recorded an
average case fatality rate of 51%, ranging from 41% in Sierra
Leone to 61% in Guinea [2]. This resulted in 28,616 cases,
11,310 deaths and over 10,000 survivors across the three
worst affected countries (Sierra Leone, Liberia and Guinea)
[3]. Sierra Leone recorded 8704 infected cases, 3589 deaths,
including 221 health workers [4]. It is estimated that a little
over 4000 survived the EVD, many of which are experien-
cing post-Ebola physical and mental health sequelae [5–8].
The psychosocial consequences of the 11-year civil war
(1991–2002) in Sierra Leone identified the need for mental
health services. It also created an increased interest in men-
tal health among researchers, policymakers, service users
and carers, religious bodies, non-governmental organisa-
tions, civil society and healthcare providers. This lead to the
establishment of mental health coalition in 2011 [9] and
the enactment of the Mental Health Policy in 2012, which
serves as a framework for the development of mental health
services [10]. Despite this progress, access to quality mental
health services is still a challenge as there are health system
and community barriers that limit the delivery of effective
mental health service [11]. Currently, Sierra Leone has two
psychiatrists, two Clinical Psychologists and 19 mental
health nurses that provide service to 7 million population
[12]. Although the recent Mental Health Strategic Plan
2014–2018 provides a roadmap for the development of
mental health curriculum, mental health course at tertiary
health training institutions are still relatively non-existence
[13]. The recent Ebola epidemic and mudslide further
highlighted the dire need for mental health services consid-
ering the trauma affected communities (Ebola and mud-
slide survivors) were exposed to during and after such a
devastating health and disaster emergencies respectively [5,
14]. A study in Western Urban and Western Rural districts
of Sierra Leone indicated that EVD risk behaviours were
significantly associated with symptoms of depression and
post-traumatic stress disorder (PTSD) in the general popu-
lation [15]. A nationwide survey also found that anxiety, de-
pression and PTSD symptoms were prevalent in the
general population a year after the end of the EVD response
[16]. With the care of Ebola survivors integrated within the
existing free health care program for pregnant women, lac-
tating mothers and under-five children [17], it is expected
Ebola survivors will have increased access to health services
including mental health. To provide better mental health
services to Ebola survivors, an understanding of the mental
health status and their needs is crucial in informing policy
and practice, which will improve resources to address men-
tal health service gaps in Sierra Leone.
A review of the literature suggests that several sociodemo-
graphic and lifestyle characteristics have been shown to be
associated with anxiety, depression and PTSD. For example,
high rates of anxiety and depression were reported among
females than males [18–20]. Also, low physical activity has
been reported to be associated with an increased rate of anx-
iety and depression [21, 22]. In addition, studies have re-
ported an association between increased alcohol intake and
the development of anxiety and depressive symptoms among
the general and sub-health populations [23–25].
Despite the disease experience of EVD survivors meet-
ing the criteria of a traumatic event as defined in the DSM
IV [26], there is a paucity of data with regards the long-
term mental health impact among survivors. Several stud-
ies reported varying degree of psychiatric morbidity (de-
pression, anxiety and post-traumatic stress disorder)
among survivors in Guinea [27, 28], Liberia [29] and Si-
erra Leone [30–32]. Most of these studies were conducted
at the peak of the outbreak using brief symptom-based
tools and small sample sizes. Also, the Sierra Leonean
studies failed to determine the socio = demographic and
health-related correlates of the symptoms of anxiety, de-
pressions and posttraumatic disorder. Thus, the aim of
this study was to determine the prevalence and predictive
factors of anxiety, depression and posttraumatic stress dis-
order among EVD survivors 2 years after discharge from
an Ebola treatment centre (ETC).
Method
Study design and settings
We conducted a cross-sectional study among Ebola sur-
vivors residing in the Bombali district, Northern Sierra
Leone, who visit the Bombali EVD Survivor Care Clinic.
The Bombali EVD, Survivor Care Clinic, was established
in October 2015 as a result of a partnership among the
following institutions-Direct Relief, Medical Research
Centre (MRC), and University of Makeni (UNIMAK),
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the Sierra Leone Ministry of Health and Sanitation
(MoHS) and the Bombali EVD Survivor Association.
The clinic provides outpatient services to survivors res-
iding in the Bombali district and its environs. The clinic
also provides referral services if needed to specialised
care, at tertiary public health facilities within and outside
the district. The services provided in the clinic include
but are not limited to eye health, mental health aware-
ness raising and sensitisation about Ebola survivorship.
Sociodemographic characteristics and other Ebola-related
variables
The sociodemographic characteristics include age (≤ 30
years, 30–49 years and > 50 years) sex (male / female), level
of education (No formal education, primary, secondary and
tertiary) marital status (single, married, divorced and
widowed) and monthly income (< Le500, 000, Le 500,000–
Le1, 000,000 and > Le1000, 000). Ebola-related variables ex-
plored include their past medical history of psychiatric ill-
ness prior to being diagnosed of Ebola (yes/no), the effect
of the death of friend or relative (Not affected, slightly af-
fected, badly affected and not applicable), number of
current post-Ebola sequelae (none, 1–2 and > 2) and num-
ber of emotional support (none, 1–2 and > 2), knowledge of
a relative or friend who died of Ebola (yes/no), alcohol sta-
tus before (yes/no) and after Ebola (yes/no) and level of ex-
ercise after Ebola (increased, decreased, remain the same,
not applicable) and alcohol intake after Ebola (increased,
decreased, remain the same, not applicable).
Main outcomes measures
Anxiety and depression among Ebola survivors were
assessed using the Hospital Anxiety and Depression
(HADS) Scale. The (HADS) Scale is a 14-item scale used
to measure symptoms of anxiety and depression in the
hospital, primary healthcare facility and among the gen-
eral population [33]. The choice to use HADS scale was
informed by the fact that it has been used to measure
anxiety and depression among survivors of a similar
post-infectious disease outbreak such as Severe Acute
Respiratory Syndrome (SARS) [34]. The HADS scale has
previously been used in Sierra Leone among ex-Ebola
Treatment Centre (ETC) staff [35]. The HADS scale
consists of seven items for the anxiety subscale and
seven for the depression subscale. The anxiety subscale
focused on symptoms of generalised anxiety disorder,
and the depression subscale focused on anhedonia,
which is considered the main symptom of depression
[36]. Ebola survivors were asked to tick a particular re-
sponse that they think is closest to how they have been
feeling in the past week. Each of the 14 items was scored
on a response scale with four alternatives that ranged
from 0 to 3. The total score for each participant ranges
from 0 to 21. Higher scores implied higher anxiety and
depression levels. For both anxiety and depression, we
used the recommended cut off score of 8 and above ac-
cording to a clinically tested classification of psychiatric
morbidity [33, 37, 38]. A score of ≥8 indicates a possible
case of anxiety and depression, [33, 37, 38]. The HADS
scale presents high internal consistency; Cronbach’s
alpha coefficient was 0.884 (0.829 for anxiety and 0.840
for depression) and stability (test-retest intra-class cor-
relation coefficient 0.944) with high concurrent validity
[33]. Permission to use the HADS scale was obtained
from GL Assessment Limited (Supplementary file 1).
The PTSD- checklist (PCL), a 17-item self-report meas-
ure of the 17 Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition (DSM-IV) symptoms of PTSD
was used to assess their level of PTSD among Ebola survi-
vors. The PCL has been used to screen individuals for
PTSD, diagnose PTSD, and monitor symptom change dur-
ing and after treatment [39]. Intrusion, avoidance, and hy-
perarousal were considered as the primary domains of
measurement with a higher internal consistency coefficient
(Cronbach’s alpha of 0.939). Respondents indicate how
much they have been bothered by a symptom over the past
month using a 5-point (1–5) Likert scale. Responses ranged
from 1 (Not at All) to 5 (extremely). We calculated the total
symptom severity score (range = 17–85) for each partici-
pant [40]. A total score (45–85) was considered as a pos-
sible case of PTSD. A higher cut-off point score was used
to identify definite cases and to minimise false positives
[40]. The index trauma for PTSD in our study was the time
of EVD diagnosis, and the time since the index trauma oc-
curred to the time of data collection between 18 and 36
months. The PCL has been used in Sierra Leone among
ex-Ebola Treatment Centre (ETC) staff [35] and other
West African populations [41]. We did not obtain permis-
sion to use this tool given that this tool is available freely
online and not copyrighted [42].
Patient population and sampling method
A convenience sampling method was employed to re-
cruit Ebola survivors into our study. An Ebola survivor
was defined in our study as an adult (18 years and older)
with a confirmed positive result on RT-PCR testing for
Ebola virus on any body fluid who was treated success-
fully and discharged and with an EVD discharge certifi-
cate [43]. Ebola survivors attending the clinic during the
period of data collection were recruited into the study.
EVD survivor status was confirmed by comparing the
clinic’s register with the Sierra Leone Association of
Ebola Survivors registry of patients residing in the Bom-
bali District and its environs, regardless of where they
were originally treated. We excluded survivors who had
severe physical or mental sequelae such as earing prob-
lems that limit their participation in the study.
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Data collection procedure
The data collection period was between May and August
2017, and it was done either by face-to-face interview in
Krio (widely spoken language in Sierra Leone) for those
who were illiterate or through self-administration of the
anxiety, depression and PTSD instruments (for those who
were literate). We initially piloted anxiety, depression and
PTSD instruments among 10 EVD survivors whose data
were excluded in the final data analysis. We explored the
possibility of using self-administered and interviewer-
administered formats of data collection during the piloting
of the study instruments. No significant difference was ob-
served between the two data collection procedures based
on the feedback we received. To ensure that we collect ac-
curate information using both data collection formats, the
self-administered format was only allowed for survivors
with tertiary education who indicated their willingness to
answer the questions on their own.
We also sent the study instruments to public health, infec-
tious disease and mental health experts for review. This was
followed by group discussions among researchers, linguistic
expert and data collectors to reach a consensus in a bid to
minimise error during the data collection process. We trained
two pharmacy professionals, a community health officer and
a nurse from the Bombali District Health Management Team
(DHMT) as data collectors on the overall research protocol,
informed consent, confidentiality, data collection techniques
and quality assurance. We held a stakeholder meeting with
the management of the clinic and the DHMT, where we ex-
plained the full protocol of the research. The clinic coordin-
ator approached adults Ebola survivors attending the clinic
during the period of data collection. EVD survivors were in-
vited to take part in the study after explaining to them about
the research. EVD survivors were taken through the partici-
pant information sheet, the informed consent form and those
that consented and signed or thumb-printed the informed
consent form were interviewed. Participants were informed
of their right to opt-out of the study at any point if they wish
to discontinue without any explanation, and that they would
not receive direct benefit from participating, other than the
psychosocial support they will receive for those that score
above the threshold.
Ethical clearance
The Sierra Leone Ethics and Scientific Review Committee,
Ministry of Health and Sanitation gave ethical approval
before the start of the study. Written informed consent
was obtained from participant either by signing or thumb
printing (illiterate participants) the consent form.
Data analysis
Data analysis was done using SPSS Package version 24
(SPSS, Inc.; Chicago). Descriptive statistics such as
means and standard deviation as well as frequency and
percentages were used to report continuous and categor-
ical variables respectively. Chi-square or Fisher exact was
used to test for associations between the independent vari-
ables (age, sex, marital status, number of emotional sup-
ports etc) and outcome variables (anxiety, depression and
post-traumatic stress disorder). In the univariate, bivariate
and multivariate analysis, anxiety, depression and PTSD
scores were converted into binary variable based on their
respective cut-off scores. A score of < 8 was considered as
no possible case of anxiety and depression. A score ≥ 8
was considered as a possible case of anxiety and depres-
sion. With regards to PTSD, a score < 45 was considered as
no possible case of PTSD. A score ≥ 45 was considered as a
possible case of PTSD. Independent variables, i.e. demo-
graphic and health-related variables with p-value ≤0.25 in
the bivariate analysis, i.e. Chi-square or Fisher exact test,
were entered into the univariate model in order to determine
the odd crude ratio. Independent variables with p ≤ 0.05 were
then entered into the multivariable logistic regression model
to determine factors that were independently associated with
outcome variables (anxiety, depression and PTSD). Statistical
significance was defined as a two-tailed, p-value less than
0.05 for all inferential analysis.
Results
Sociodemographic characteristics of Ebola survivors
Of 245 Ebola survivors approached, 197 agreed to partici-
pate in the study giving a response rate of 80.4%. Table 1
summarises the sociodemographic characteristics of Ebola
survivors. Majority (n = 167, 84.8%) were below the age of
50 years, and half (n = 99, 50.3%) of them were females.
Close to half (n = 84, 42.6%) were single. More than two-
third (n = 140, 71.1%) were badly affected as a result of the
death of a friend or a relative due to Ebola, whereas the
exercise level among more than half (n = 110, 55.8%) of
survivors decreased after recovery. Our study adheres to
the STROBE guidelines for cross-sectional studies. Please
see supplementary file 2 for details.
Prevalence of anxiety, depression and PTSD
Table 2 presents the summary statistics of the anxiety,
depression and PTSD. The mean anxiety, depression
and PTSD scores were (5.0 ± 3.9), (7.1 ± 3.8) and (39.5 ±
6.4) respectively. Table 2 also indicates that close to a
quarter (n = 49, 24.9%), close to half (n = 93, 47.2%) and
close to a quarter (n = 43, 21.8%) of survivors inter-
viewed showed a possible case of anxiety, depression
and PTSD respectively.
Association between anxiety, depression, PTSD and
demographic variables
Table 3 highlights the association between anxiety, de-
pression, PTSD and the demographic variables. Age,
death of friend or relative, alcohol intake before Ebola,
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level of exercise after Ebola and knowing a relative or a
friend that died due to Ebola was associated with the
symptoms of anxiety among survivors. Number of emo-
tional supports received age, the number of post-Ebola
symptoms experienced, alcohol intake before and after
Ebola and level of exercise after Ebola were associated
with symptoms of depression among survivors. However,
no sociodemographic and health-related characteristics
were associated with symptoms of PTSD among survivors.
Predictors of anxiety, depression and PTSD among Ebola
survivors
Tables 4 and 5 indicate that older Ebola survivors (≥30
years) were more likely to show symptoms of depression
(AOR = 8.5, 95%CI: 2.68–27.01, p = 0.001) and anxiety
(AOR = 3.04; 95%CI: 1.2–7.7, p = 0.019) compared to
younger ones (< 30 years). In addition, Ebola survivors
who experience a decreased level of exercise post-ETC
discharge were more likely to show symptoms of depres-
sion (AOR = 2.63; 95%CI: 1.25–5.54, p = 0.011) and anx-
iety (AOR = 3.60; 95%CI: 1.33–9.72, p = 0.012) compared
to those whose exercise remained the same post-ETC
discharge. On the other hand, Table 6 shows that none
of the sociodemographic variables considered in our
study was a predictor of PTSD among survivors.
Discussion
Several studies have reported the prevalence of symptoms
of psychological distress among Ebola survivors immedi-
ately after being infected or shortly after discharge from
the Ebola treatment centre [5, 6]. However, there is pau-
city of data on the long-term mental health effects among
those who survived Ebola virus disease. This is the first
ever-quantitative study that assessed the long-term preva-
lence and predictors of the symptoms of anxiety, depres-
sion and post-traumatic stress disorder among Ebola
survivors in Sierra Leone. Our study is aimed to provide
an insight into the long-term psychological morbidity and
its possible risk factors among Ebola survivors in Sierra
Leone in order to inform ongoing policy and practice
related to providing care to Ebola survivors.
Our study indicates that close to a quarter (24.9%) of
survivors exhibited a possible case of anxiety which is
slightly higher than those reported by Nanyonga et al. [31]
and Mohamed et al. [44] in Kenema, Eastern Sierra Leone.
Although studies from East Africa [45–47] and in Guinea
[28], Nigeria [48] Liberia [49] and within Sierra Leone [30,
50–52] using quantitative and qualitative research designs
have reported that psychological harm is common among
Ebola survivors, it has failed to assess anxiety among Ebola
survivors specifically, and this makes comparison among
studies to be difficult. For instance, a study by Ji et al. in
Sierra Leone, anxiety was part of positive symptom dis-
tress index (PSDI) that was used to evaluate psychological
Table 1 demographics of Ebola survivors (n = 197)
Characteristics Variables N (%)
Age Group < 30 years 87(44.2)
30-49 years 80(40.6)
≥50 years 30(15.2)
Sex Male 98(49.7)
Female 99(50.3)
Marital status Single 84(42.6)
Married 59(29.9)
Divorced 13(6.6)
Widow/widower 41(20.8)
Monthly income level < Le500, 000 141(71.6)
Le 500,000– Le1,
000,000
52(26.4)
>Le1000, 000 4(2.0)
Educational status Non-formal
education
73(37.1)
Primary education 32(16.2)
Secondary
education
68(34.5)
Tertiary education 24(12.2)
Number of emotional support None 7(3.6)
1–2 70(35.5)
> 2 120(60.9)
Effect of death of friend or relative Not affected 9(4.6)
Slightly affected 29(14.7)
Badly affected 140(71.1)
Not applicable 19(9.6)
Number of current post-Ebola
sequelae
None 22(11.2)
1–2 45(22.8)
> 2 130(66.0)
Past psychiatric history prior to
being diagnosed with Ebola
Yes 8(4.1)
No 189(95.9)
Alcohol intake before Ebola Yes 60(30.5)
No 137(69.5)
Alcohol intake after Ebola Increased 12(6.1)
Decreased 31(15.7)
Remain the same 23(11.7)
Not applicable 131(66.5)
Level of exercise after Ebola Increased 33(16.8)
Decreased 110(55.8)
Remain the same 50(25.4)
Not applicable 4(2.0)
Knowledge of relative or friend death
due to Ebola
Yes 179(90.9)
No 18(9.1)
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distress among Ebola survivors, medical personnel and lo-
gistics workers [51]. In reporting, only the PSDI score was
reported, and it was higher among Ebola survivors com-
pared to non-survivors [51].
With regards to depression, our study indicates that
close to half (47.2%) of Ebola survivors interviewed show
possible case of depression. Our result is slightly above a
similar study conducted in Liberia among 82 survivors,
6 months following their discharge from ETC [53] It is
also higher than the prevalence reported among survivors
in eastern Sierra Leone (35%) that were assessed 4 months
post-ETC discharge [31].. In addition, a cohort study in
Guinea among survivors most of which were assessed
8 months post-ETC discharge, reported a lower preva-
lence of depressive symptoms (15%) although three, thir-
teen and eleven of the 33 survivors who were assessed by
a psychiatrist show mild, moderate and severe depression
respectively [54]. Self-perceived depression was reported
in 1% of survivors in another Guinean study [27]. The
variation observed between our finding with that of other
findings from other studies may be due to differences in
the post ETC discharge time when Ebola survivors were
assessed. It may also be due to the use of different evalu-
ation tools to assess depression as well as the varied socio-
cultural dynamics and coping mechanisms employed by
survivors in each of the study areas.
Post-traumatic stress disorder is a mental disorder that
is common among individuals that have experienced se-
vere trauma such a war, sexual violence or deadly infec-
tious disease outbreak such as EVD. Our study reports
that close to a quarter (21%) of EVD survivors inter-
viewed, showed a possible case of PTSD. A similar
prevalence of post-traumatic stress reactions three-four
weeks post-ETC discharge which is predictive of PTSD
was reported in a study by Hugo and colleagues in
Kailahun-Eastern Sierra Leone [30]. The reason for such
similarity in our findings may be due to coincidence. Fu-
ture nationwide studies should explore whether our
findings hold true in other parts of Sierra Leone and
other Ebola-affected countries. Compared to other infec-
tious disease outbreaks, in our study, our PTSD preva-
lence is slightly lower than that reported on SARS
survivors in Hong Kong [34]..
Our study revealed that symptoms of anxiety and de-
pression were more common among survivors above the
age of 30 years and whose rate of exercise has decreased
after surviving Ebola. Low physical activity was found to
be associated with anxiety and depression among chronic
disease patients in Myanmar and Vietnam [22]. Physical
activity should be part of mental health promotion inter-
ventions given that increase physical activity and low sed-
entary behaviour are known to improve depressive [21, 55]
and anxiety [56] symptoms in survivors of other chronic
disease conditions. In addition to physical exercise,
evidence-based mental health interventions such as Behav-
ioural Activation (BA) need to be explored as part of men-
tal health care interventions given that BA- as part of the
Youth Readiness Intervention (YRI) - has been proven to
be effective in the treatment of symptoms of common
mental disorders such as depression among war-affected
youths in Sierra Leone. Although further research into our
reported associations is needed, our findings suggest that
being old and decreased physical activity, which might be
due to the widely reported musculoskeletal complications
among EVD survivors [7] may be specific risk factors for
anxiety and depression among Ebola survivors and may
warrant early and focused support services. Even though
studies have reported a positive correlation between
increased alcohol intake and high rates of anxiety and
depression [23–25], results from our regression analyses
did not find alcohol intake as a statistically significant pre-
dictor of anxiety, depression and PTSD among Ebola sur-
vivors. Differences in sample population, socio-economic
and cultural context as well as in the use of study instru-
ments may help explain why there were no significant as-
sociations between alcohol intake and anxiety, depression
as well as PTSD. Further large-scale studies are required
to ascertain whether a positive association between alcohol
intake and anxiety, depression as well as PTSD.
We observed in our study that none of the sociodemo-
graphic variables considered is a possible predictor of
symptoms of post-traumatic stress disorder experienced
by survivors although a study among Severe Acute Re-
spiratory Syndrome (SARS) survivors reported that being
female and the presence of chronic health condition diag-
nosed before being infected with SARS were predictors of
PTSD among SARS survivors in Hong Kong [57]. It is
worthy to note that even though the general literature sug-
gests that the rates of depression and anxiety can be higher
among females than males [18–20, 58, 59], analysis of our
Table 2 Prevalence of anxiety, depression and PTSD
Anxiety scale Mean (SD) 5.0 (3.9)
Possible case of anxiety (HADS cut-off score≥ 8) n (%) 49(24.9)
Depression scale Mean (SD) 7.1(3.8)
Possible case of depression (HADs cut-off score≥ 8) n (%) 93(47.2)
PTSD scale Mean (SD) 39.5(6.4)
Possible case of PTSD (cut-off score≥ 45) n (%) 43(21.8)
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data suggest that there is no statistically significant associ-
ation between the rates of depression and anxiety and gen-
der in our study (see Table 3). Reasons for this may be due
to differences in the traumatic event that triggered their
psychological distress, in this case, being infected with the
Ebola virus. It may also be due to differences in resilience/
coping mechanism developed in responding to the
traumatic event. Another reason maybe linked to the sam-
ple size used and the fact that a non-probability sampling
method was used in our study.
Policy and clinical implications and future direction
In light of the relatively high prevalence of symptoms of
anxiety, depression and PTSD, the care for Ebola
Table 5 Predictors of depression among Ebola survivors
Characteristics Variables OR (95%CI) P-value Adjusted OR(95%CI) P-value
Age Group < 30 years 1 < 0.001 1 0.001
≥30 years 9.70(3.24–29.06) 8.51(2.68–27.01)
Number of emotional support None 1 –
1–2 1.06(0.22–5.10) 0.942 –
> 2 0.50(0.11–2.33 0.378 –
Number of sequelae experienced None 1 –
1–2 1.81(0.64–5.10) 0.260 –
> 2 0.69(0.28–1.70) 0.419 –
Alcohol intake before Ebola No 1 0.003 1
Yes 2.58(1.38–4.82) 0.10(0.24–4.21) 0.998
Alcohol intake after Ebola Increased 1.52(0.47–4.97) 0.489 2.68(0.47–15.18) 0.265
Decreased 2.76(1.22–2.64) 0.015 1.63(0.36–7.43) 0.531
same 2.85(1.13–7.20) 0.027 1.67(0.32–8.83) 0.546
Not drinking 1 1 1
Level of exercise after Ebola Remains the same 1 1
Increased 1.00(0.40–2.51) 1.00 0.84(0.29–2.43) 0.747
Decreased 2.78(1.41–5.50) 0.003 2.63(1.25–5.54) 0.011
Table 4 Predictors of anxiety among Ebola survivors
Characteristics Variables OR (95%CI) P-value Adjusted OR (95%CI) P-value
Age Group < 30 years 1 0.001 1 0.019
≥30 years 3.91(1.74–8.78) 3.04(1.20–7.70)
Number of emotional support None 1 –
1–2 0.53(0.11–2.60) 0.437 –
> 2 0.37(0.08–1.75) 0.210 –
Effect of death of friend or relative Not affected 1 1
Slightly affected 0.09(0.02–0.55) 0.009 0.04(0.01–0.32) 0.002
Badly affected 0.23(0.06–0.90) 0.035 0.12(0.03–0.58) 0.008
Not applicable 0.89(0.18–4.38) 0.885 0.51(0.09–3.03) 0.462
Past psychiatric history No 1 0.178 –
Yes 2.54(0.66–9.87 –
Alcohol intake before Ebola No 1 0.031 1
Yes 2.10(1.07–4.11) 1.93(0.85–4.35) 0.115
Level of exercise after Ebola Remains the same 1 1
Increased 1.20(0.35–4.14) 0.774 1.30(0.34–4.50) 0.700
Decreased 3.40(1.40–8.26) 0.007 3.60(1.33–9.72) 0.012
Knowledge of relative or friend death due to Ebola No 1 0.051 – –
Yes 0.37(0.14–1.00) – –
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survivors should not only focus on the treatment of phys-
ical conditions. Healthcare workers providing care to sur-
vivors should be aware of the possible long-term
psychological complications, especially symptoms of anx-
iety, depression and PTSD. As it has been reported in pre-
vious studies among the general population in Sierra
Leone [15, 16], our study further highlights the signifi-
cance of detecting and managing psychiatric morbidity
among survivors following a devastating and traumatic
event or an infectious disease outbreak such as Ebola.
For future outbreaks or other traumatic events, the de-
sign and execution of response during and after the out-
break should factor in the high possibility of the increasing
incidence of mental health morbidities as it has been ob-
served in other infectious disease outbreaks [60]. The
training of mental health staff and the integration of men-
tal health into the existing primary healthcare system will
contribute to improving access to psychosocial care in a
country where access to mental health care is limited. Psy-
chosocial support with self-copying strategies is needed to
enhance survivors’ resilience in dealing with anxiety, de-
pression and PTSD. The application of disaster response
management knowledge and skills can be useful while
awaiting further research evidence on the effectiveness of
psychosocial interventions given the fact that Ebola shares
a similar clinical pattern of psychiatric morbidity with
other disasters. The Cognitive-behavioural therapy (CBT)
is a mental health intervention that can be used to manage
psychiatric morbidity among survivors in Sierra Leone
given that previous Sierra Leonean studies have reported
the effectiveness of CBT in improving the mental health,
social behaviour, and school functioning among war-
affected youth [61] and ex-Ebola Treatment Centre staff
[35]. Also, the use of group interpersonal therapy (IPT)
needs to be explored as it was effective in treating depres-
sive symptoms in Uganda [62] and South Africa [63].
Future longitudinal cohort studies are required to
understand the trajectory of mental health morbidities
among Ebola survivors. Multicentre or cross-country
studies are needed to unearth any cultural differences that
may exist and come up with findings that are applicable to
a wider population. The psychological impact of Ebola on
at risk populations such as pregnant women, children,
immediate relatives of Ebola survivors and survivors of re-
cent natural disaster in Sierra Leone is an area worth
exploring.
Strengths and limitations
To the best of our knowledge, this is the first study that
has explored the long-term psychological complications
among Ebola survivors in Sierra Leone. However, the in-
terpretation of our findings should be done with caution,
considering the following limitations. Our findings are
only representative of Bombali district and not the whole
of Sierra Leone. Although we used widely used pre-
validated instruments to measure anxiety, depression
and PTSD, none of them was validated in Sierra Leone
before the conduct of our study. As such, we were un-
able to validate the clinical cut-off point for anxiety, de-
pression and PTSD among the Ebola survivors that
participated in our study. Instead, we used clinical cut-
off points based on the available literature [33, 36, 37,
40]. In addition, comparison of our findings with others
was difficult since, to the best of our knowledge, these
studies used different tools to measure symptoms of
anxiety, depression and PTSD among the Ebola survi-
vors. Our study was conducted without a control group,
and that makes interpretation of our findings is little bit
challenging. In our study, we rely on self-report to meas-
ure anxiety, depression and PTSD as well as retrospect-
ive reporting of some of the sociodemographic and
lifestyle characteristics. As such, we cannot totally rule
out the possibility of recall bias. We excluded Ebola sur-
vivors with hearing impairment, which may limit their
ability to provide information accurately. Although the
demographic characteristics of Ebola survivors excluded
are similar to those included in our study, it is possible
that those excluded may have provided different re-
sponses to questions asked in our study. The index
trauma for PTSD in our study was the time of EVD
diagnosis. However, we were unable to report the time
since the index trauma occurred to the time of data col-
lection for each Ebola survivors.
Owing to the cross-sectional design, the present study
only described anxiety, depression and PTSD symptoms
of Ebola survivors 2 years after the end of the Ebola out-
break in Sierra Leone. Longitudinal studies are required
in order to monitor changes over time.
Conclusion
Our study suggests that anxiety, depression and PTSD are
common among Ebola survivors in Bombali district,
Northern Sierra Leone. Also, our findings suggest that be-
ing above the age of 30 years and decreased rate of exer-
cise after surviving Ebola are likely predictors of anxiety
and depression but PTSD among Ebola survivors. Our
study further underscores the importance of detecting and
Table 6 Predictors of Post-traumatic stress disorder (PTSD)
among Ebola survivors
Characteristics Variables OR
(95%CI)
P-
value
Adjusted
OR
P-
value
Alcohol intake before
Ebola
No 1
Yes 1.92(0.95–
3.87)
0.069 –
Knowledge of relative
or friend death due
to Ebola
No 1
Yes 2.38(0.53–
10.77)
0.261 –
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managing mental health morbidities among survivors after
exposure to an infectious disease outbreak such as Ebola.
Cognitive Behaviour Therapy (CBT) and Interpersonal
Therapy (IPT) need to be explored as part of overall men-
tal healthcare package interventions.
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